X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Pfizer with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs ADCOCK INGRAM (S. Africa) - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PFIZER   ADCOCK INGRAM
EQUITY SHARE DATA
    PFIZER
Mar-18
ADCOCK INGRAM
Jun-14
PFIZER/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs2,365344-   
Low Rs1,625248-   
Sales per share (Unadj.) Rs430.3102.2-  
Earnings per share (Unadj.) Rs78.7-25.8-  
Cash flow per share (Unadj.) Rs93.2-21.3-  
Dividends per share (Unadj.) Rs20.000-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs586.580.2-  
Shares outstanding (eoy) m45.75168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.62.9 160.2%   
Avg P/E ratio x25.3-11.5 -220.8%  
P/CF ratio (eoy) x21.4-13.9 -154.5%  
Price / Book Value ratio x3.43.7 92.3%  
Dividend payout %25.40-   
Avg Mkt Cap Rs m91,27149,921 182.8%   
No. of employees `0002.64.3 61.3%   
Total wages/salary Rs m3,1433,133 100.3%   
Avg. sales/employee Rs Th7,484.84,019.0 186.2%   
Avg. wages/employee Rs Th1,195.0729.8 163.7%   
Avg. net profit/employee Rs Th1,369.1-1,012.7 -135.2%   
INCOME DATA
Net Sales Rs m19,68517,254 114.1%  
Other income Rs m1,143121 945.9%   
Total revenues Rs m20,82817,374 119.9%   
Gross profit Rs m5,003-2,990 -167.3%  
Depreciation Rs m663745 89.0%   
Interest Rs m4467 0.9%   
Profit before tax Rs m5,479-4,081 -134.3%   
Minority Interest Rs m0-11 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,878255 736.6%   
Profit after tax Rs m3,601-4,348 -82.8%  
Gross profit margin %25.4-17.3 -146.7%  
Effective tax rate %34.3-6.2 -548.7%   
Net profit margin %18.3-25.2 -72.6%  
BALANCE SHEET DATA
Current assets Rs m24,16712,637 191.2%   
Current liabilities Rs m9,5447,110 134.2%   
Net working cap to sales %74.332.0 231.9%  
Current ratio x2.51.8 142.5%  
Inventory Days Days55111 49.7%  
Debtors Days Days29124 23.2%  
Net fixed assets Rs m9,5147,366 129.2%   
Share capital Rs m45880 571.1%   
"Free" reserves Rs m26,3750-   
Net worth Rs m26,83213,542 198.1%   
Long term debt Rs m254,759 0.5%   
Total assets Rs m36,90025,582 144.2%  
Interest coverage x1,305.5-7.7 -16,884.4%   
Debt to equity ratio x00.4 0.3%  
Sales to assets ratio x0.50.7 79.1%   
Return on assets %9.8-15.2 -64.4%  
Return on equity %13.4-32.1 -41.8%  
Return on capital %20.4-19.8 -103.1%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-1,4660-   
CASH FLOW
From Operations Rs m3,3181,473 225.3%  
From Investments Rs m-2,383-452 527.0%  
From Financial Activity Rs m-1,1044,319 -25.5%  
Net Cashflow Rs m-1695,340 -3.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.74 Rs / ZAR

Compare PFIZER With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare PFIZER With: AJANTA PHARMA  SUVEN LIFESCIENCES  ORCHID PHARMA LTD  UNICHEM LAB  AUROBINDO PHARMA  



Today's Market

Indian Indices Continue Momentum; Sensex Ends 268 Points Higher(Closing)

After opening the day marginally higher, Indian share markets continued their momentum and ended their day on a positive note.

Related Views On News

PFIZER Announces Quarterly Results (3QFY19); Net Profit Up 51.2% (Quarterly Result Update)

Jan 25, 2019 | Updated on Jan 25, 2019

For the quarter ended December 2018, PFIZER has posted a net profit of Rs 1 bn (up 51.2% YoY). Sales on the other hand came in at Rs 5 bn (up 12.5% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of PFIZER for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PFIZER. Also includes updates on the valuation of PFIZER.

PFIZER Announces Quarterly Results (2QFY19); Net Profit Down 13.8% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, PFIZER has posted a net profit of Rs 958 m (down 13.8% YoY). Sales on the other hand came in at Rs 5 bn (down 9.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Are You Ready for the Big Nifty Move in the March Expiry?(Profit Hunter)

Mar 8, 2019

History suggests the Nifty could make a big move in March. Are you prepared to benefit from this opportunity?

Smallcaps Are Rallying and You Need to Make the Most of It Now(Profit Hunter)

Mar 7, 2019

Did you just miss the smallcap rally? Or is there still time to catch up? Read on for answers and more...

The One Sector to Bet on Today as India Grows into a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Mar 7, 2019

India's defence sector is suddenly under the spotlight. Can this sector ride along India's long-term growth story?

Is it the Right Time to Buy Mid and Small Caps Now?(The 5 Minute Wrapup)

Mar 6, 2019

Mid and Small Caps have underperformed large caps in the past year. Is the tide about to turn?

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Mar 19, 2019 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS